We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Seegene

Seegene, Inc. is a developer of multiplex molecular technologies and multiplex clinical molecular diagnostics for inf... read more Featured Products: More products

Download Mobile App





Seegene Dispalys Connected Molecular Diagnostic Platforms at ADLM 2026

By LabMedica International staff writers
Posted on 30 Jul 2026

Seegene (Seoul, South Korea) is highlighting the integration of laboratory automation and real-time diagnostic data analysis at ADLM 2026 in Anaheim, California. More...

At booth 3517, visitors can explore the CURECA automated PCR system through guided tours and experience the STAgora connected data platform in an immersive demonstration zone.

CURECA is designed to automate the complete PCR testing workflow, beginning with the pre-treatment of primary specimens and continuing through nucleic acid extraction, amplification, and result analysis. Its modular architecture is intended to reduce manual intervention and support continuous specimen processing across laboratories with different operational requirements.

A dedicated CURECA Prep module handles specimen types that traditionally require manual preparation, including urine, blood, sputum, and stool. By incorporating this step into the automated workflow, the system is designed to standardize sample handling, reduce reliance on specialized personnel, and enable uninterrupted molecular testing.

Seegene is also showcasing STAgora, a connected platform that integrates PCR testing data generated across different laboratories and regions. The system analyzes and visualizes aggregated results to provide users with real-time views of local, national, and global infectious disease trends.

STAgora can display pathogen-specific positivity rates, regional infection patterns, and co-infection trends derived from syndromic PCR testing. More than 40 statistical tools support functions including abnormal-pattern detection, infection-rate monitoring, seasonal analysis, and predictive modeling for emerging outbreaks.


Gold Member
Aspiration System
VACUSAFE
Online QC Software
Acusera 24•7
Hematology Consumables
Bioblood Devices
Immunofluorescence Analyzer
IFA System
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Illustration of the new blood test, which uses a DNA chip to detect the tumor’s biological fingerprint (Photo courtesy of Tel Aviv University)

Blood Test on a Chip Offers Low-Cost Lung Cancer Detection Without DNA Sequencing

Lung cancer is the leading cause of cancer deaths worldwide, and screening often yields indeterminate results that prompt invasive workups. Computed tomography (CT) detects small nodules but can flag benign... Read more

Molecular Diagnostics

view channel
Image Credit: Adobe Stock

Whole-Cell Genomic Analysis Expands the Potential of Liquid Biopsy

Liquid biopsy has expanded access to tumor genomics, but most blood-based assays rely on short, degraded fragments of cell-free circulating tumor DNA (ctDNA). Isolating intact circulating tumor cells from... Read more

Microbiology

view channel
Image: An innovative countywide program in Taiwan combines risk-based screening with decentralized community care to improve hepatitis C detection and treatment (Image Credit: iStock)

Precision Screening Helps Close Hepatitis C Diagnosis and Treatment Gaps

Hepatitis C remains a leading cause of cirrhosis and liver cancer, yet many infections go undiagnosed or untreated because health systems fail to reach those at greatest risk. Although highly effective... Read more

Pathology

view channel
Image: Through the PCCP, Proscia gains a more efficient pathway to expand Concentriq AP-Dx interoperability while maintaining regulatory oversight (Photo courtesy of Proscia)

FDA-Cleared Digital Pathology Platform Expands Interoperability for Primary Diagnosis

Rising cancer incidence is colliding with a shrinking pathologist workforce, intensifying pressure on diagnostic turnaround times in clinical laboratories. Many labs are adopting digital pathology to manage... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.